Why CRPS-RISE? CRPS-RISE (NCT07210515) is a Phase 3 randomized, triple-blind, placebo-controlled clinical trial evaluating neridronate as a potential new treatment option for Complex Regional Pain Syndrome Type 1 (CRPS-1), a rare and debilitating condition with an annual incidence of ~65,0001 and currently no FDA-approved medicine in...
[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_column_text css=""] This study will examine the effects of mindfulness meditation and therapeutic hypnosis on chronic pain management. Evidence suggests that both mindfulness meditation and therapeutic hypnosis can help individuals manage their pain and improve their quality of life....
We are seeking caregivers who provide care for family members with dementia and pain to participate in a research study at Weill Cornell Medicine. This study is evaluating the “Pain Identification and Communication Toolkit (PICT)”, a novel intervention to help caregivers recognize and communicate about...
Use the link below to send a message to the study coordinator, or call the number above to speak directly with a study representative.
